Skip to content

Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett´s esophagus

Comparison of confocal laser microscopy (CLM) probe with bioptic histology for detection of neoplasia in patients with Barrett's esophagus

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12608000124336
Enrollment
39
Registered
2008-03-10
Start date
2006-10-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Use of endoscope guided in vivo miniprobe confocal laser microscopy in the diagnosis of Barrett neoplasia. Each patient will be examined once at their presentation for Barrett surveillance examination.

Sponsors

Charite University Hospitals Berlin
Lead SponsorHospital

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Diagnosis
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

All patients with known Barrett esophagus who present for an upper endoscopy (EGD)

Exclusion criteria

Phase I (establishment of CLM neoplasia criteria) - none. Phase II (testing of criteria) - only patients with no apparent macroscopic lesions within the Barrett segment.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026